Can-Fite will immediately exercise warrants covering up to 1,591,738 ADSs at $2.50 each, seeking approximately $4.0 million in gross proceeds. The cash matters because Can-Fite intends to direct net proceeds toward research and development, clinical trials, Working Capital and general corporate purposes, subject to customary closing conditions.
Key Highlights
- Can-Fite will exercise warrants covering up to 1,591,738 ADSs at $2.50 per ADS.
- The transaction includes new unregistered warrants for up to 3,183,476 ADSs, also priced at $2.50 per ADS.
- H.C. Wainwright & Co. is serving as exclusive Placement agent, with closing expected on or about September 3.
Can-Fite BioPharma Ltd. (AMEX: CANF) expects approximately $4.0 million in gross cash proceeds from an immediate Warrant exercise, before placement fees and offering expenses. The transaction is subject to customary closing conditions and is expected to close on or about September 3, with net proceeds intended for research, Clinical Trials and corporate needs.
Warrant Terms and Registration Plans
The agreement covers outstanding warrants issued in March 2026, originally carrying a $5.00 exercise price per ADS. Can-Fite will reduce that price to $2.50 for the immediate cash exercise of warrants covering up to 1,591,738 ADSs. In return, Can-Fite will issue new unregistered warrants covering up to 3,183,476 ADSs, with an exercise price of $2.50 per ADS.
Research and Clinical Funding
The new warrants were offered through a private placement relying on an exemption from registration requirements under the 1933 Act.
Peers Moving on This News
FAQs
Q: How much money will Can-Fite BioPharma raise from the warrant exercise?
A: Can-Fite expects approximately $4.0 million in gross proceeds from the cash exercise of outstanding warrants. Placement agent fees and offering expenses will be deducted.
Q: What are the terms of Can-Fite’s new ADS warrants?
A: Can-Fite will issue new unregistered warrants for up to 3,183,476 ADSs. The new warrants will carry a $2.50 exercise price per ADS.
Q: When is Can-Fite’s warrant transaction expected to close?
A: The closing is expected on or about September 3, subject to customary closing conditions. H.C. Wainwright & Co. is the exclusive placement agent for the offering.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.